Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07044466 · ClinicalTrials.gov registry record · NA

Social Functioning in Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
230
Enrollment target
1
Study location

NCT07044466: Recruiting NA study of Opioid Use Disorder, sponsored by Medical University of South Carolina.

NCT07044466 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 230 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07044466, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
230 participants
Enrollment target
1
Study location

Study Summary

Problems with social functioning are core to opioid use disorder (OUD), though specific, modifiable social functioning targets and how they relate to OUD treatment outcomes are poorly understood. This study will utilize both data from both patients with OUD and their concerned significant other (CSO) to examine associations between specific social functioning metrics and OUD treatment outcomes. Findings from this study will inform future precision-medicine approaches for people with OUD, a population in significant need of enhanced treatment approaches to combat opioid morbidity and mortality.

Primary Outcome

Checklist of 12 items assessing social interaction behaviors (adapted from the Social Behavior Inventory; Moskowitz, 1994), summed, averaged, and ipsatized to assess dominant behavior, submissive behavior, agreeable behavior, and quarrelsome behavior. Higher scores reflect greater frequency of the type of behavior.

Conditions Studied

Interventions

  • BEHAVIORAL CBT4CBT-Buprenorphine

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2026-02-23
Est. Completion 2029-08-31
Phase NA

What NCT07044466 shows while recruiting

NCT07044466 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which CBT4CBT-Buprenorphine is the first listed.

NCT07044466 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT07044466 about?

NCT07044466 is a clinical study titled "Social Functioning in Opioid Use Disorder". Problems with social functioning are core to opioid use disorder (OUD), though specific, modifiable social functioning targets and how they relate to OUD treatment outcomes are poorly understood. This study will utilize both data from both patients with OUD and their concerned significant other (CSO...

What is the current status of trial NCT07044466?

This trial is currently recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2026-02-23. Estimated completion is 2029-08-31.

What conditions does trial NCT07044466 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT07044466?

The interventions under investigation include: CBT4CBT-Buprenorphine (BEHAVIORAL).

Who is sponsoring clinical trial NCT07044466?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07044466 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07044466's enrollment target sits among peer trials

230 79th of 257 higher than 178 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07044466, the US trial registry maintained by the National Library of Medicine. NCT07044466 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.